Interleukin-18 acts as an angiogenesis and tumor suppressor

FASEB Journal

Volumn 13, Issue 15, 1999, Pages 2195-2202

  Cao, Renhai ^a   Farnebo, Jacob ^a   Kurimoto, Masashi ^b   Cao, Yihai ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

Author keywords

Antitumor; Interferon ; Neovascularization

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; INTERLEUKIN 18;

ANGIOGENESIS; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CAPILLARY ENDOTHELIUM; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; GROWTH INHIBITION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 0032786495     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.13.15.2195     Document Type: Article

References (51)

1. Hanahan, D., and Folkman, J. (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364
2. Risau, W. (1997) Mechanisms of angiogenesis. Nature (London) 386, 671-674
3. Folkman, J., and D'Amore, P. (1996) Blood vessel formation: What is its molecular basis? Cell 87, 1153-1155
4. Folkman, J. (1997) Addressing tumor blood vessels. Nature (London) Biotech. 15, 510
5. Folkman, J. (1995) Clinical applications of research on angiogenesis. N. Engl. J. Med. 333, 1757-1763
6. Folkman, J. (1995) Angiogenesis in cancer, vascular rheumatoid and other disease. Nature (London) Med. 1, 27-31
7. Boehm, T., Folkman, J., Browder, T., and O'Reilly, M. S. (1997) Antiangiogenic therapy of experimental cancer does not induce aquired drug resistance. Nature (London) 390, 404-407
8. Kim, J. B., Li, B., Winer, J., Armanini, M., Gillet, N., Phillips, H. S., and Ferrara, N. (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature (London) 362, 841-844
9. Brooks, P. C., Montgomery, A. M., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., and Cheresh, D. A. (1994) Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157-1164
10. Millauer, B., Shawver, L. K., Plate, K. H., Risau, W., and Ullrich, A. (1994) Glioblastoma growth inhibited in vitro by a dominant-negative Flk-1 mutant. Nature (London) 367, 578-579
11. Handel, J., Bossy-Wetzel, E., Radvanyi, F., Klagsbrun, M., Folkman, J., and Hanahan, D. (1991) Neovascularization is associated with a switch to the export of bFGF in the mutistep development of fibrosarcoma. Cell 66, 1095-1104
12. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R.A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., and Folkman, J. (1994) Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328
13. O'Reilly, M. S., Holmgren, L., Chen, C., and Folkman, J. (1996) Angiostatin induces and sustains dormancy of human primary tumors in mice. Nature Med 2, 689-692
14. O'Reilly, M. S., Boehm, T., Shing, Y., Fuhai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B., and Folkman, J. (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 1-20
15. Cao, Y. (1998) Endogenous angiogenesis inhibitors: angiostatin, endostatin and other proteolytic fragments. Progr. Mol. Subcell. Biol. 20, 161-176
16. Strieter, R. M., Polverini, P. J., Arenberg, D. A., and Kunkel, S. L. (1995) The role of CXC chemokines as regulators of angiogenesis. Shock 4, 155-160
17. Kock, A. E., Polverini, P. J., Kunkel, S. L., Harlow, L. A., DiPietro, L. A., Elner, V. M., Elner, S. G., and Strieter, R. M. (1992) Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science (Wash. DC) 256, 1798-1801
18. Hu, D. E., Hori, Y., and Fan, T. D. P. (1993) Interleukin-8 stimulates angiogenesis in rats. Inflammation 17, 135-143
19. Fukushi, J., Morisaki, T., Shono, T., Nishie, A., Torisu, H., Ono, M., and Kuwano, M. (1998) Novel biological functions of interleukin-4: Formation of tube-like structures by vascular endothelial cells in vitro and angiogenesis in vivo. Biochem. Biophys. Res. Commun. 250, 444-448
20. Maione, T. E., Gray, G. S., Petro, A. J., Hunt, A. L., and Donner, S. I. (1990) Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 247, 77-79
21. Angiolillo, A. L., Sgadari, C., Taub, D. D., Liao, F., Farber, J. M., Meaheshwari, S., Kleinman, H. K., Reaman, G. H., and Tosato, G. (1995) Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J. Exp. Med 182, 155-162
22. Arenberg, D. A., Kunkel, S. L., Polverini, P. J., Morris, S. B., Burdick, M. D., Glass, M. C., Taub, D. T., Iannettoni, M. D., Whyte, R. I., and Stricter, R. M. (1996) Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J. Exp. Med. 184, 981-992
23. Luster, A. D., Greenberg, S. M., and Leder, P. (1995) The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J. Exp. Med. 182, 219-231
24. Cao, Y., Chen, C., Weatherbee, J. A., Tsang, M., and Folkman, J. (1995) Gro-beta, a -C-X-C- chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice. J. Exp. Med. 182, 2069-2077
25. Ezekowitz, R. A. B., Mulliken, J., and Folkman, J. (1995) Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N. Engl. J. Med. 333, 595-596
26. Tepper, R. I., and Bouck, N. P. (1998) Inhibition of angiogenesis by interleukin 4. J. Exp. Med. 188, 1039-1046
27. Voest, E. E., Kenyon, B. M., O'Reilly, M. S., Truitt, G., D'Amato, R. J., and Folkman, J. (1995) Inhibition of angiogenesis in vivo by interleukin-12. Natl. Cancer Inst. 87, 581;nd586
28. Maione, T. E., Gray, G. S., Petro, J., Hunt, A. J., Donner, A. L., Bauer, S. I., Carson, H. F., and Sharpe, R. J. (1991) Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity. Cancer Res. 51, 1798-1801
29. Luster, A. D., and Leder, P. (1993) IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo. J. Exp. Med. 178, 1057-1065
30. Lieschke, G. J., Rao, P. K., Gately, M. K., and Mulligan, R. C. (1997) Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in vivo. Nature (London) Biotech. 15, 35-40
31. Okamura, H., Tsutsi, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Torigoe, K., Okura, T., Nukada, Y., Hattori, K., Aklta, K., Namba, M., Tanabe, F., Konishi, K., Fukuda, S., and Kurimuto, M. (1995) Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature (London) 378, 88-91
32. Coughlin, C. M., Salhany, K. E., Wysocka, M., Aruga, E., Kurzawa, H., Chang, A. E., Hunter, C. A., Fox, J. C., Trinchieri, G., and Lee W. H. F. (1998) Interleukin-12 and interleukin 18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J. Clin. Invest. 101, 1441-1452
33. Udagawa, N., Horwood, N. J., Elliott, J., Mackay, A., Owens, J., Okamura, H., Kurimoto, M., Chambers, T. J., Martin, T. J., and Gillespie, M. T. (1997) Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoblast formation. J. Exp. Med. 185, 1005-1012
34. Folkman, J., Haudenschild, C. C., and Zetter, B. R. (1979) Long-term culture of capillary endothelial cells. Proc. Natl. Acad. Sci. USA 76, 5217-5121
35. Muthukkaruppan, V. R., and Auerbach, R. (1979) Angiogenesis in the mouse cornea. Science 205, 1416-1418
36. Chen, C., Parangi, S., Tolentino, M., and Folkman, J. (1995) A strategy to discover circulating angiogenesis inhibitors generated by human tumors. Cancer Res. 55, 4230-4233
37. Kenyon, B. M., Voest, E. E., Chen, C., Flynn, E., Folkman, J., and D'Amato, R. J. (1996) A model of angiogenesis in the mouse cornea. Invest. Ophthalmol. Vis. Sci. 37, 1625-1632
38. Cao, Y., Linden, P., Shima, D., Browne, F., and Folkman, J. (1996) In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor. J. Clin. Invest. 98, 2507-2511
39. Cao, Y., Ji, R.-W., Davidson, D., Schaller, J., Marti, D., Sohndel, S., McCance, S. G., O'Reilly, M. S., Llinas, M., and Folkman, J. (1996) Kringle domains of human plasminogen: Characterization of the anti-proliferative activity of endothelial cells. J. Biol. Chem. 271, 29461;nd29467
40. Cao, Y., Chen, A., An, S. S. A., Ji, R. W., Davidson, D., Cao, Y., and Llinas, M. (1997) Kringle 5 of plasminogen is a novel inhibitor for endothelial cell growth. J. Biol. Chem. 272, 22924-22928
41. Cao, Y., O'Reilly, M. S., Marshall, B., Flynn, E., Ji, W. R., and Folkman, J. (1998) Expression of angiostatin cDNA in a murine T241 fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases. J. Clin. Invest. 101, 1055-1063
42. Jain, R. K., Schlenger, K., Hockel, M., and Yuan, F. (1997) Quantitive angiogenesis assays: Progress and problems. Nature Med. 3, 1203-1208
43. Dao, T., Ohashi, K., Kayano, T., Kurimoto, M., and Okamura, H. (1996) Interferon-γ-inducing factor, a novel cytokine, enhances fas ligand-mediated cytotoxicity of murine T helper 1 cells. Cell. Immunol. 173, 230-235
44. Ushio, S., Namba, M., Okura, T., Hattori, K., Nukada, Y., Akita, K., Tanabe, F., Konishi, K., Micallef, M., Fujii, M., Torigoe, K., Tanimoto, T., Fukuda, S., Ikeda, M., Okamura, H., and Kurimoto, M. (1996) Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biological activities of the protein. J. Immuol. 156, 4274-4279
45. Ghayur, T., Banerjee, S., Hugunin, M., Butler, D., Herzog, L., Carter, A., Quintal, L., Sekut, L., Talanian, R., Paskind, M., Wong, W., Kamen, R., Tracey, D., and Allen, H. (1997) Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature (London) 386, 619-623
46. Gu, Y., Kuida, K., Tsutsui, H., Ku, G., Hsiao, K., Fleming, M. A., Hayashi, N., Higashino, K., Okamura, H., Nakanishi, K., Kurimoto, M., Tanimoto, T., Flavell, R. A., Sato, V., Harding, M. W., Livingston, D. J., and Su, M. S. (1997) Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science 275, 206-209
47. Cerretti, D. P., Kozlosky, C. J., Mosley, B., Nelson, N., Van Ness, K., Greenstreet, T. A., March, C. J., Kronheim, S. R., Druck, T., and Cannizzaro, L. A. (1992) Molecular cloning of the interleukin-1 beta converting enzyme. Science 256, 97-100
48. Ahn, H. J., Maruo, S., Tomura, M., Mu, J., Hamaoka, T., Nakanishi, K., Kurimoto, M., Okamura, H., and Fujiward, H. (1997) A mechanism underlying synergy between IL-12 and IFN-gamma-inducing factor in enhanced production of IFN-gamma. J. Immunol. 159, 2125-2131
49. Cohn, M. J., Izpisua-Belmonte, J. C., Abud, H., Heath, J. K., and Tickle, C. (1995) Fibroblast growth factors induce additional limb development from the flank of chick embryo. Cell 80, 739-746
50. Folkman, J. (1971) Tumor angiogenesis. N. Engl. J. Med. 285, 1182-1186
51. Sarvetnick, N. (1997) IFN-γ, IGIF, and IDDM. J. Clin. Ivest. 99, 371-372